News | Radiation Therapy | August 17, 2015

Accuray Tops User Satisfaction Ratings in MD Buyline Report

Company received highest composite score in all categories including system performance, reliability and application training

Accuray, highest composite rating, user satisfaction, MD Buyline

August 17, 2015 — Accuray Inc. announced that its CyberKnife and TomoTherapy systems have received the highest composite overall user satisfaction rating among radiation treatment delivery systems in the United States, according to the Q2 2015 MD Buyline Market Intelligence Briefing. The most recent ratings trend also shows Accuray has achieved the highest ratings among industry peers over the past two years.

  In rating Accuray, MD Buyline reports the company obtained the highest scores in all categories measured including system performance, system reliability, installation/implementation, application training and system response. CyberKnife and TomoTherapy system users continue to report Accuray products as "user-friendly" and "highly reliable," with system downtimes being "rare." Accuray personnel also received strong marks, with customers praising "their knowledge and ability to effectively communicate" with them.

MD Buyline, an independent market intelligence organization for the healthcare industry, measures linear accelerator user satisfaction based on evaluations by more than 3,300 hospitals in its member network that use the product every day. Respondents rate how satisfied they are with products from Accuray, Elekta and Varian, using key metrics listed above along with installation and implementation, applications training and service repair quality.

For more information: www.accuray.com

Related Content

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.